Latest News

Several Department of Pathology faculty members were among more than 100 Yale physicians recognized as top doctors in Connecticut by Connecticut Magazine in its annual Top Doctors issue.

Over 40 Yale Cancer Center researchers will share advances for new therapies at the 2025 ASCO Annual Meeting with research areas covering breast, lung, prostate, head and neck, early onset, and metastatic cancers.

In honor of National Cancer Research Month, Dr. Jeffrey Townsend shares why his research is focused on cancer.

Answers to questions about the causes, warning signs, symptoms and treatments for cancers of the mouth, throat, tongue, and all Head and Neck cancers

Excerpts from a recent conversation on Yale Cancer Answers on Connecticut Public Radio between Peter Glazer, MD, PhD and Eric Winer, MD, the director of the Yale Cancer Center and president and physician-in-chief of the Smilow Cancer Hospital in New Haven.

A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024

Cancers of the head and neck are relatively rare, accounting for less than 4% of cases in the United States, but they are extremely complicated to treat because they attack essential daily functions. A Smilow specialty team coordinates treatment from start to finish.

Barbara Burtness, MD, Anthony N. Brady Professor of Medicine (Medical Oncology), Chief Translational Research Officer at Yale Cancer Center, and Chief of Head and Neck Cancers/Sarcoma, and Maryam Lustberg, MD, MPH, Associate Professor of Internal Medicine (Medical Oncology) and Chief of Breast Medical Oncology, have been named Fellows of the American Society of Clinical Oncology (FASCO).

Dr. Barbara Burtness Receives Presidential Citation from AAO-HNS.